Company intelligence / Profile preview

Myzone

Nottingham, United Kingdom

Ownership: Private
Development stage: Other

Overview

Myzone develops and markets health and wellness wearables, primarily heart rate monitors like the MZ-Switch, and a digital health platform that gamifies exercise via personalized effort scoring (Myzone Effort Points - MEP system). Its products are widely used in gyms, health clubs, corporates, education, and elite sports, boasting high accuracy for heart rate and caloric expenditure. The company is not involved in pharmaceutical R&D, therapeutics, or traditional clinical trials.

Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

BGF (investment partner)Vin Murria OBE (Non-executive chair and investor)

Beyond the preview

Go deeper on Myzone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myzone.

Explore the full profile